Rhonda Farnum's most recent trade in Theravance Biopharma Inc was a trade of 9,096 Ordinary Shares done at an average price of $13.4 . Disclosure was reported to the exchange on Aug. 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.39 per share. | 20 Aug 2025 | 9,096 | 317,822 (0%) | 0% | 13.4 | 121,795 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 11.39 per share. | 14 Jul 2025 | 5,318 | 330,918 (0%) | 0% | 11.4 | 60,548 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 11.39 per share. | 14 Jul 2025 | 4,000 | 326,918 (0%) | 0% | 11.4 | 45,552 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 11.39 per share. | 14 Jul 2025 | 682 | 336,236 (0%) | 0% | 11.4 | 7,770 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 02 Jun 2025 | 24,000 | 336,918 (0%) | 0% | 11 | 264,000 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.45 per share. | 20 May 2025 | 9,120 | 360,918 (0%) | 0% | 9.5 | 86,184 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 21 Apr 2025 | 4,000 | 370,038 (0%) | 0% | 9 | 36,000 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 75,000 | 374,038 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.66 per share. | 10 Feb 2025 | 15,810 | 299,038 (0%) | 0% | 9.7 | 152,725 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 5,283 | 314,848 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 21 Jan 2025 | 4,000 | 309,565 (0%) | 0% | 9 | 36,000 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.97 per share. | 20 Nov 2024 | 9,178 | 313,565 (0%) | 0% | 10.0 | 91,505 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 11 Nov 2024 | 4,000 | 322,743 (0%) | 0% | 9 | 36,000 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.22 per share. | 20 Aug 2024 | 9,222 | 326,743 (0%) | 0% | 8.2 | 75,805 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 10 Jul 2024 | 4,000 | 335,965 (0%) | 0% | 9 | 36,000 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.10 per share. | 20 May 2024 | 9,268 | 339,965 (0%) | 0% | 9.1 | 84,339 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 37,500 | 349,233 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.92 per share. | 20 Feb 2024 | 18,219 | 312,987 (0%) | 0% | 8.9 | 162,513 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 8.71 per share. | 20 Feb 2024 | 1,254 | 311,733 (0%) | 0% | 8.7 | 10,922 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 9.47 per share. | 22 Aug 2023 | 1,807 | 340,566 (0%) | 0% | 9.5 | 17,112 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.70 per share. | 20 Aug 2023 | 10,460 | 342,373 (0%) | 0% | 9.7 | 101,462 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 11.13 per share. | 08 Jun 2023 | 1,790 | 352,833 (0%) | 0% | 11.1 | 19,923 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.21 per share. | 20 May 2023 | 5,567 | 354,623 (0%) | 0% | 11.2 | 62,406 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 10.20 per share. | 09 Mar 2023 | 4,000 | 360,190 (0%) | 0% | 10.2 | 40,800 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 75,000 | 364,190 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.44 per share. | 20 Feb 2023 | 7,119 | 289,190 (0%) | 0% | 10.4 | 74,322 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.85 per share. | 20 Nov 2022 | 23,268 | 296,309 (0%) | 0% | 10.9 | 252,458 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.34 per share. | 19 Aug 2022 | 10,413 | 319,577 (0%) | 0% | 9.3 | 97,257 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.74 per share. | 20 May 2022 | 2,200 | 331,071 (0%) | 0% | 8.7 | 19,228 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 8.93 per share. | 20 May 2022 | 1,081 | 329,990 (0%) | 0% | 8.9 | 9,653 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Sale of securities on an exchange or to another person at price $ 10.16 per share. | 28 Feb 2022 | 2,356 | 333,271 (0%) | 0% | 10.2 | 23,947 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.61 per share. | 18 Feb 2022 | 11,824 | 335,627 (0%) | 0% | 9.6 | 113,629 | Ordinary Shares |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, Comm & Medical Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 27,500 | 347,451 (0%) | 0% | 0 | Ordinary Shares |